Pertussis Toxin Ameliorates Microglial Activation Associated With Ischemic Stroke

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Microglia play a critical role in the brain's response to injury, including cerebral ischemia.
• Dysregulated microglial activation can exacerbate neuronal damage following stroke.
• Pertussis toxin (PTX) is known to modulate immune cell function.

Purpose of the Study:

• To investigate the therapeutic potential of Pertussis toxin (PTX) in cerebral ischemia.
• To elucidate the mechanisms by which PTX affects microglial activity and inflammatory responses in stroke models.

Main Methods:

• A middle cerebral artery occlusion (MCAO) stroke model in rodents was used to assess PTX's effects on neurological function, infarct size, and microglial behavior.
• Primary microglial cultures were utilized to examine PTX's impact on proliferation, activation, cytokine release (IL-1β, TNF-α), and CX3CR1 expression.

Main Results:

• PTX treatment significantly reduced infarct volume and improved neurological scores in the MCAO model.
• PTX decreased microglial aggregation and activation in the ischemic brain regions.
• In vitro, PTX inhibited lipopolysaccharide-induced microglial proliferation, pro-inflammatory cytokine release (IL-1β, TNF-α), and CX3CR1 expression.

Conclusions:

• Pertussis toxin demonstrates neuroprotective effects in a rodent model of cerebral ischemia.
• PTX mitigates stroke-induced brain damage by suppressing detrimental microglial activation and reducing the production of key inflammatory mediators.
• These findings suggest PTX as a potential therapeutic agent for ischemic stroke, acting via modulation of microglial inflammatory pathways.